Skip to main content

ciclosporin (Ikervis®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisa TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears

Medicine details

Medicine name ciclosporin (Ikervis®)
Formulation 1 mg/ml eye drops
Reference number 2176
Indication

Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes

Company Santen Pharmaceutical
BNF chapter Eye
Submission type N/A
Status Excluded due to NICE appraisal
Date of issue 24/02/2015
NICE guidance

TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears

Follow AWTTC: